PT Kimia Farma (KAEF):企業の財務・戦略的SWOT分析

◆英語タイトル:PT Kimia Farma (KAEF) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0062
◆発行会社(調査会社):GlobalData
◆発行日:2019年11月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インドネシア
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

PT Kimia Farma (KAEF) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

PT Kimia Farma (Kimia Farma) manufactures, commercializes and distributes pharmaceutical products. The company provides ethical (prescription), generic and other products. It offers products in various categories including alimentary system, allergy and immune system, system anaesthetic, local and general antibiotic, antidotes and detoxifying, cardiovascular and hematopoietic, dermatological, eye and ear, genito – urinary system, hormones, intravenous and other sterile, metabolism, neuromuscular, other chemoterapetics, respiratory, vitamin and minerals and others. Kimia Farma distributes its products in various countries across the world including Asia, Europe and Africa. The company operates manufacturing plants in Jakarta, Bandung, Semarang, Watudakon, Medan and West Java. Kimia Farma is headquartered in Jakarta, Indonesia.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
PT Kimia Farma – Key Facts
PT Kimia Farma – Key Employees
PT Kimia Farma – Major Products and Services
PT Kimia Farma – History
PT Kimia Farma – Company Statement
PT Kimia Farma – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
PT Kimia Farma – Business Description
Business Segment: Distribution Segment
Overview
Performance
Business Segment: Manufacturing Segment
Overview
Performance
Business Segment: Other Segment
Performance
Business Segment: Retail Segment
Overview
Performance
R&D Overview
PT Kimia Farma – Corporate Strategy
PT Kimia Farma – SWOT Analysis
SWOT Analysis – Overview
PT Kimia Farma – Strengths
PT Kimia Farma – Weaknesses
PT Kimia Farma – Opportunities
PT Kimia Farma – Threats
PT Kimia Farma – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
PT Kimia Farma, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
PT Kimia Farma, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
PT Kimia Farma, Recent Deals Summary
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
PT Kimia Farma, Key Facts
PT Kimia Farma, Key Employees
PT Kimia Farma, Major Products and Services
PT Kimia Farma, History
PT Kimia Farma, Other Locations
PT Kimia Farma, Subsidiaries
PT Kimia Farma, Joint Venture
PT Kimia Farma, Key Competitors
PT Kimia Farma, Ratios based on current share price
PT Kimia Farma, Annual Ratios
PT Kimia Farma, Annual Ratios (Cont...1)
PT Kimia Farma, Annual Ratios (Cont...2)
PT Kimia Farma, Interim Ratios
PT Kimia Farma, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
PT Kimia Farma, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
PT Kimia Farma, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
PT Kimia Farma, Performance Chart (2014 - 2018)
PT Kimia Farma, Ratio Charts
PT Kimia Farma, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
PT Kimia Farma, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[PT Kimia Farma (KAEF):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CytoBioscience Inc:医療機器:M&Aディール及び事業提携情報
    Summary CytoBioscience Inc (CytoBioscience), formerly Cytocentrics Bioscience GmbH is a biotechnology company that manufactures of medical devices for ion channel research. The company’s products include CytoPatch instrumentations. It provides services such as adult human heart, expression systems, …
  • Public Financial Holdings Ltd (626)
    Public Financial Holdings Ltd (626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Adenovir Pharma AB-製薬・医療分野:企業M&A・提携分析
    Summary Adenovir Pharma AB (Adenovir Pharma) is a drug development company that develops antiviral medicinal solutions for the treatment of infectious diseases such as adenoviral conjunctivitis and epidemic keratoconjunctivitis affecting the eyes. The company’s products are eye drops which acts outs …
  • Engie SA (ENGI):企業の財務・戦略的SWOT分析
    Engie SA (ENGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Intech Biopharm Ltd (6461):製薬・医療:M&Aディール及び事業提携情報
    Summary Intech Biopharm Ltd (Intech Biopharm) is a drug developing company that develops drugs for obstructive airway diseases. The company provides marketed products such as single ingredient generics such as Synvent, and Duasma, developed for asthma; and multi-ingredient generic, Synflutide, for a …
  • The Chugoku Electric Power Co Inc:発電所・企業SWOT分析
    The Chugoku Electric Power Co Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Emera (Caribbean) Inc.:企業の戦略的SWOT分析
    Emera (Caribbean) Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Molecular Partners AG (MOLN):製薬・医療:M&Aディール及び事業提携情報
    Summary Molecular Partners AG (Molecular Partners) is a clinical stage biopharmaceutical company that provides biological drugs. The company provides advanced pipeline products such as abicipar, a designed ankyrin repeat protein based anti-angiogenic drug developed for diabetic macular edema and wet …
  • Great Western Bancorp Inc:企業の戦略・SWOT・財務分析
    Great Western Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary Great Western Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Enzymotec Ltd:企業の戦略・SWOT・財務情報
    Enzymotec Ltd - Strategy, SWOT and Corporate Finance Report Summary Enzymotec Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Landesbank Baden-Wurttemberg:企業のM&A・事業提携・投資動向
    Landesbank Baden-Wurttemberg - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Landesbank Baden-Wurttemberg Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • MediaValet Inc.:企業の戦略・SWOT・財務情報
    MediaValet Inc. - Strategy, SWOT and Corporate Finance Report Summary MediaValet Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • NACHI-FUJIKOSHI CORP.:企業の戦略・SWOT・財務情報
    NACHI-FUJIKOSHI CORP. - Strategy, SWOT and Corporate Finance Report Summary NACHI-FUJIKOSHI CORP. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • McKinsey & Co Inc:企業の戦略的SWOT分析
    McKinsey & Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Totally Plc (TLY):企業の財務・戦略的SWOT分析
    Summary Totally plc (Totally) is a healthcare service provider that offers positive health and financial solutions. The center designs, implements and delivers coaching services to the healthcare sector, and supports individuals to better understand their healthcare options. It offers treatments and …
  • Great-West Life & Annuity Insurance Co:企業の戦略的SWOT分析
    Great-West Life & Annuity Insurance Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Accenture Plc (ACN):企業の財務・戦略的SWOT分析
    Accenture Plc (ACN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Reviva Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Reviva Pharmaceuticals Inc (Reviva Pharma) is a clinical development pharmaceutical company that develops therapeutic drugs. The company develops drugs in the therapeutic areas of cardiovascular, metabolic, central nervous system and inflammatory diseases. Its product pipeline comprises RP50 …
  • Ecolab Inc.:企業の戦略・SWOT・財務分析
    Ecolab Inc. - Strategy, SWOT and Corporate Finance Report Summary Ecolab Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Senju Pharmaceutical Co Ltd:企業の戦略的SWOT分析
    Senju Pharmaceutical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆